Dkm Pharma Private Limited - Due diligence report

A 360° intelligence report on Dkm Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

2018-05-21 Braddhaman Egara,Raniganj, West Bengal Active Unlisted
Share
DP Dkm Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Dkm Pharma — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Dkm Pharma is assessed as Low Risk with a Trust Score of 81/100. Dkm Pharma is an active private limited indian non-government company incorporated in 2018, operating in the Chemicals sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Dkm Pharma Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SASWATI CHAKRABORTY 01234567 Director 01/04/2018 6 yrs Approved
SUJAN MUKHERJEE 01234567 Director 01/04/2018 6 yrs Approved
BIJAN KUMAR MUKHOPADHYAY 01234567 Director 01/04/2018 6 yrs Approved
SOURAV BHATTACHARJEE 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 80
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
04 Dec 2019
Director appointed
SUJAN MUKHERJEE (Additional Director)
05 Jul 2019
Director appointed
SASWATI CHAKRABORTY (Additional Director)
21 May 2018
Incorporated
Registered with Roc Kolkata Ii
Director appointed
BIJAN KUMAR MUKHOPADHYAY (Director)
Director appointed
SOURAV BHATTACHARJEE (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Asvp Pharma Health Industries Private Limited U24299KL2019PTC057002 Parakunnam, Kerala, India
Dr. Avitosh Medicare Private Limited U24230CT2019PTC009073 Kumhari, Chattisgarh, India
Spyron Innovative Solutions Private Limited U24100BR2019PTC042340 Purnia, Bihar, India
Sri Ratnam Agarbatti & Services Private Limited U24299BR2017PTC036077 Patna, Bihar, India
Samprisn Org.Ayuveda Private Limited U24246DL2018PTC341180 Delhi, Delhi, India
Sjcouture Private Limited U18209HR2017PTC071384 Gurgaon, Haryana, India
Marllon Healthcare Private Limited U24232TN2019PTC130810 Chennai, Tamil Nadu, India
Panter India Textile Machinery Private Limited U18209GJ2017PTC097368 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Dkm Pharma before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Dkm Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Dkm Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Dkm Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dkm Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Dkm Pharma an active company?

Dkm Pharma has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Dkm Pharma financially healthy?

Dkm Pharma has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.

Should I do business with Dkm Pharma?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Dkm Pharma?

See the directors and ownership sections above for board and shareholding detail. 4 active director(s) are on record.

Does Dkm Pharma have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Dkm Pharma up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Dkm Pharma?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.